In the unprecedented move announced in the 2024-25 Mid-Year Economic and Fiscal Outlook, the copy recommended by the Medical Services Advisory Committee would be funded despite no evaluation or approval by the Therapeutic Goods Administration. …
Novartis joins legal action against unapproved copy of radioligand therapy
February 25, 2025 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Percheron Therapeutics launches bonus loyalty option offer
May 7, 2025 - - Australian Biotech -
OncoSil Medical reports positive results of pancreatic cancer analysis
May 7, 2025 - - Australian Biotech -
CLINUVEL recruits 200 patients for Phase 3 vitiligo trial of SCENESSE
May 7, 2025 - - Australian Biotech -
Pharmacy Guild calls for standardisation of access to asthma treatment
May 6, 2025 - - Latest News -
Trump administration moves to streamline pharma manufacturing while increasing global inspections
May 6, 2025 - - Latest News -
Sigma delivers continued growth following the completion of Chemist Warehouse merger
May 6, 2025 - - Latest News -
Greg Hunt to chair new telehealth sector working group
May 6, 2025 - - Latest News